Loading...
2018–2019 Drug Updates in Hematologic Malignancies
Lauren Held, PharmD, BCOP, updated attendees on the FDA-approved therapies for initial or expanded indications for hematologic malignancies across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and...
Na minha lista:
| Udgivet i: | J Adv Pract Oncol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Harborside Press LLC
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857325/ https://ncbi.nlm.nih.gov/pubmed/33598320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.3.7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|